Patient Provided Data
From Patient Determinants
Cognitive Screening
- Mindstrong is developing objective measures of brain function based on patterns of interaction with a smartphone. Digital biomarkers Mindstrong measures include processing speed, attention, memory and executive function. The company is led by former NIMH director Dr. Thomas Insel (6/19/17)
- FDA provided clearance for CANTAB Mobile app that helps screen for Alzheimer’s and cognitive impairment (3/1/17)
- Savonix developed a mobile, evidence-based neurocognitive assessment platform that eliminates the need for pen and paper exams that screen for cognitive functions. (2/2/17)
Health Risk Assessment
Patient-Reported Outcomes
Virtual Physician Assistant